ProStabilize injection, for subcutaneous use, contains Tirzepatide, a once weekly GIP receptor and GLP-1 receptor agonist. It is a 39-amino-acid modified peptide based on the GIP sequence.
Dosage & Administration
The recommended starting dosage of ProStabilize is 2.5 mg injected subcutaneously once weekly. The 2.5 mg dosage is for treatment initiation and is not intended for glycemic control.
After 4 weeks, increase the dosage to 5 mg injected subcutaneously once weekly.
If additional glycemic control is needed, increase the dosage in 2.5 mg increments after at least 4 weeks on the current dose.
The maximum dosage of ProStabilize is 15 mg injected subcutaneously once weekly.
Storage & Handling
Store ProStabilize in a refrigerator at 2°C to 8°C.
Do not freeze ProStabilize. Do not use ProStabilize if frozen.
Store ProStabilize in the original carton to protect from light.
Request more details about ProStabilize 15mg